The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation

Trial Profile

The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 10 Mar 2016

At a glance

  • Drugs Tegaserod (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 10 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top